首页> 外文期刊>American Journal of Surgical Pathology >Lymphatic vascular invasion in ovarian serous tumors of low malignant potential with stromal microinvasion: a case control study.
【24h】

Lymphatic vascular invasion in ovarian serous tumors of low malignant potential with stromal microinvasion: a case control study.

机译:低恶性卵巢浆液性肿瘤伴间质微浸润的淋巴管浸润:病例对照研究。

获取原文
获取原文并翻译 | 示例
           

摘要

Stromal microinvasion in ovarian serous tumors of low malignant potential (S-LMP) stratifies patients at long-term risk for disease progression independent of stage and primary ovarian histology. Despite the histologic impression and often-quoted incidence of lymphatic vascular invasion (LVI) in S-LMP with stromal microinvasion, there has been no formal evaluation in a case control series of S-LMP. The presence and extent of (LVI) was assessed in 20 S-LMP with stromal microinvasion and 20 S-LMP case controls without stromal microinvasion and compared with a series of low-grade and high-grade serous carcinomas using D2-40 monoclonal antibody recognizing podoplanin, a novel lymphatic endothelial marker. S-LMP case controls were matched for primary ovarian histology (usual vs. micropapillary), International Federation of Gynecology and Obstetrics (FIGO) stage, and age (best possible match). The patterns of stromal microinvasion included individual eosinophilic cells and cell clusters, cribriform, simple and noncomplex branching papillae, and inverted macropapillae. Immunohistologic staining with D2-40 monoclonal antibody clearly identified intratumoral LVI in 12/20 (60%) S-LMP with stromal microinvasion and 0/20 S-LMP without stromal microinvasion. Although only 4/13 (31%) low-grade serous carcinomas and 7/20 (35%) high-grade serous carcinomas had intratumoral LVI, hilar LVI was more common in the carcinomas (15% low-grade; 69% high-grade). Intratumoral LVI in S-LMP ranged from focal (6 cases) to multifocal (6 cases, maximum of 5 discrete foci) in any 1 section and included isolated single cells, simple papillae, and in 1 case, cribriform glands. Multifocal LVI was identified in 1 study patient who was pregnant. One of the 12 S-LMP patients with LVI had an intra-abdominal recurrence with high-grade disease at 16 months; whereas all other patients with follow-up were free of disease. LVI in ovarian S-LMP was significantly associated with the presence of stromal microinvasion (P<0.0001) and is independent of age, stage, primary ovarian histology, and pattern or extent of microinvasion. The presence of LVI in microinvasive S-LMP corroborates the view that microinvasion represents an early, but very low risk, invasive process that morphologically links S-LMP and low-grade serous carcinoma.
机译:低恶性卵巢浆液性肿瘤(S-LMP)中的基质微小浸润可将处于疾病进展长期风险的患者分层,而与分期和原发性卵巢组织学无关。尽管具有基质微浸润的S-LMP的组织学印象和淋巴血管浸润(LVI)的发生率经常被引用,但是在病例对照系列S-LMP中尚无正式评估。 (LVI)的存在和程度在有基质微浸润的20 S-LMP和没有基质微浸润的20 S-LMP病例对照中进行了评估,并使用D2-40单克隆抗体识别技术与一系列低度和高度浆液性癌进行了比较podoplanin,一种新型的淋巴管内皮标记。 S-LMP病例对照符合原发性卵巢组织学(通常与微乳头),国际妇产科联合会的阶段(FIGO)和年龄(最佳匹配)。基质微浸润的模式包括单个嗜酸性细胞和细胞簇,筛状,简单和非复杂的分支乳头以及倒置的大乳头。用D2-40单克隆抗体进行的免疫组织学染色清楚地鉴定了12/20(60%)S-LMP发生间质微浸润和0/20 S-LMP没有间质微浸润的肿瘤内LVI。虽然只有4/13(31%)低度浆液性癌和7/20(35%)高度浆液性癌具有瘤内LVI,但肝门LVI在癌中更为常见(15%低度; 69%高年级)。 S-LMP的瘤内LVI在任何1个切片中范围从局灶性(6例)到多灶性(6例,最多5个离散灶),包括分离的单细胞,简单的乳突和1例筛状腺。在一名孕妇中鉴定出多灶性LVI。 12例LVI的S-LMP患者中,有1例在16个月时发生腹腔内复发并伴有严重疾病。而其他所有接受随访的患者均无疾病。卵巢S-LMP中的LVI与基质微浸润的存在显着相关(P <0.0001),并且与年龄,分期,原发性卵巢组织学以及微浸润的模式或程度无关。 LVI在微浸润性S-LMP中的存在证实了微浸润是一种早期但风险非常低的浸润性过程的观点,该过程在形态学上将S-LMP与低度浆液性癌联系起来。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号